Unknown

Dataset Information

0

A scalable, virtual weight management program tailored for adults with type 2 diabetes: effects on glycemic control.


ABSTRACT:

Background

The objective was to test the efficacy of a scalable, virtually delivered, diabetes-tailored weight management program on glycemic control in adults with type 2 diabetes (T2D).

Methods

This was a single arm, three-site clinical trial. Participants had baseline HbA1c between 7-11% and BMI between 27-50 kg/m2. Primary outcome was change in HbA1c at 24 weeks. Secondary outcomes were changes in body weight, waist circumference, the Diabetes Distress Scale (DDS), quality of life (IWQOL-L), and hunger (VAS). Generalized linear effects models were used for statistical analysis.

Results

Participants (n = 136) were 56.8 ± 0.8 y (Mean ± SEM), 36.9 ± 0.5 kg/m2, 80.2% female, 62.2% non-Hispanic white. Baseline HbA1c, weight, and total DDS score were 8.0 ± 0.09%, 101.10 ± 1.47 kg, and 2.35 ± 0.08, respectively. At week 24, HbA1c, body weight, and total DDS decreased by 0.75 ± 0.11%, 5.74 ± 0.50%, 0.33 ± 0.10 units, respectively (all p < 0.001). Also, at week 24, quality of life increased by 9.0 ± 1.2 units and hunger decreased by 14.3 ± 2.4 units, (both p < 0.0001).

Conclusions

The scalable, virtually delivered T2D-tailored weight management program had favorable and clinically meaningful effects on glycemic control, body weight, and psychosocial outcomes.

SUBMITTER: Apolzan JW 

PROVIDER: S-EPMC10079927 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

A scalable, virtual weight management program tailored for adults with type 2 diabetes: effects on glycemic control.

Apolzan John W JW   LaRose Jessica Gokee JG   Anton Stephen D SD   Beyl Robbie A RA   Greenway Frank L FL   Wickham Edmond P EP   Lanoye Autumn A   Harris Melissa N MN   Martin Corby K CK   Bullard Tiffany T   Foster Gary D GD   Cardel Michelle I MI  

Nutrition & diabetes 20230406 1


<h4>Background</h4>The objective was to test the efficacy of a scalable, virtually delivered, diabetes-tailored weight management program on glycemic control in adults with type 2 diabetes (T2D).<h4>Methods</h4>This was a single arm, three-site clinical trial. Participants had baseline HbA1c between 7-11% and BMI between 27-50 kg/m<sup>2</sup>. Primary outcome was change in HbA1c at 24 weeks. Secondary outcomes were changes in body weight, waist circumference, the Diabetes Distress Scale (DDS),  ...[more]

Similar Datasets

| S-EPMC5585298 | biostudies-other
| S-EPMC6473237 | biostudies-literature
| S-EPMC2518008 | biostudies-other
| S-EPMC8413413 | biostudies-literature
| S-EPMC9445344 | biostudies-literature
| S-EPMC9998005 | biostudies-literature
| S-EPMC3594066 | biostudies-literature
| S-EPMC6969653 | biostudies-literature
| S-EPMC9934313 | biostudies-literature
| S-EPMC2705948 | biostudies-literature